2 research outputs found

    Prevalence of Mycoplasma genitalium and Mycoplasma hominis isolates among Women with Cervicitis Referred to Karaj Health Care Centers

    Get PDF
    Background and Objectives: Mycoplasma is a genus of bacteria often found in the normal flora of the mouth, respiratory system and urogenital tract; but potentially pathogenic species also exist which can cause serious respiratory and genital diseases in human including postpartum fever, pelvic inflammatory infections, and pyelonephritis. The aim of this study was to evaluate the prevalence of Mycoplasma genitalium and Mycoplasma hominis in women who referred to the health centers in Karaj and investigate the susceptibility of M. genitalium strains against Fluoroquinolone antibiotics.Materials & Methods: Endocervical swabs were taken from 200 women with cervicitis. Nucleic Acid Amplification Tests (NAATs) were performed for detecting Mgpa gene in M. genitalium and RNH gene in M. hominis. Mutations in parC and gyrA genes, as well as antibiotic resistance, were studied in positive samples of M. genitalium.Results: 9 M. genitalium and 11 M. hominis positive samples were found among samples obtained from women with cervicitis. Positive samples of M.genitalium were examined for isolating the parC and gyrA genes. Six sequences of these genes were analyzed by MEGA5 software. Mutation in parC gene was observed in one sequence which %16 shows resistance.Conclusion: M. hominis and M. genitalium were detected in 5.5% and 4.5% of samples, respectively. Our findings showed a relatively medium prevalence of M. hominis and M. genitalium in women with cervicitis in Alborz province. The sequencing results of gyrA and parC genes in this study represent the occurrence of mutations which drive fluoroquinolones resistance. Therefore, further studies are necessary in this area and to overcome this problem irregular prescribing limited and antibiotic sensitivity patterns in treatment to be considered

    The Correlation between Clumping Factor A Gene Expression in Biofilm Formation and Antibiotic Resistance Among Staphylococcus aureus Isolated from Urine Samples of Imam Khomeini Hospital, Tehran

    No full text
    Background & Objective: Staphylococcus aureus causes problems in hospitals and it has emerged as a serious agent acquired from the environment in recent years. One of the capabilities of S. aureus is the formation of biofilms, in which bacteria can exchange antibiotic-resistance genes among themselves and increase the virulence of other strains of this species (S. aureus). A surface protein attached to the cell wall in S. aureus clumping factor A is a virulence factor in various staphylococcal infections. Materials & Methods: In this study, after the Urea Analysis (UA) test, the urea culture test was applied to the blood agar and Baird-Parker Agar culture media from the infectious urine samples in Imam Hospital, Tehran, to identify S. aureus isolates. Finally, a molecular method was used for the confirmation of identified isolates. The microliter plate method was performed to determine the biofilm formation ability. The disk diffusion method was also used for profiling the antibiotic resistance of the isolates. Results: In the results of this study, 45 out of 160 urinary clinical samples were positive for S. aureus, among which 42 isolates expressed the clfA gene. Moreover, 39 isolates had the ability to form biofilms in vitro. Among these 42 isolates, the highest (88%) and the lowest (16%) rates of antibiotic resistance were observed against penicillin and cefoxitin, respectively. Data analysis with SPSS software and chi-square indicated a significant relationship between gene expression and biofilm production with antibiotic resistance (P < 0.05). Conclusion: The resistance of S. aureus bacteria is increasing strongly due to the repeated use of antibiotics such as beta-lactams, especially in respiratory infections and pharyngitis. Moreover, biofilm formation and virulence factors, such as clfA and clfB, cause concerns to the World Health Organization for treatment, especially for people with sepsis or toxemia
    corecore